EP0705108A4 - Verwendung von kryptischen peptiden zur induktion immunologisches toleranz - Google Patents

Verwendung von kryptischen peptiden zur induktion immunologisches toleranz

Info

Publication number
EP0705108A4
EP0705108A4 EP94916845A EP94916845A EP0705108A4 EP 0705108 A4 EP0705108 A4 EP 0705108A4 EP 94916845 A EP94916845 A EP 94916845A EP 94916845 A EP94916845 A EP 94916845A EP 0705108 A4 EP0705108 A4 EP 0705108A4
Authority
EP
European Patent Office
Prior art keywords
immunologic tolerance
cryptic peptides
inducing immunologic
inducing
cryptic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94916845A
Other languages
English (en)
French (fr)
Other versions
EP0705108A1 (de
Inventor
Wayne Robert Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Telethon Kids Institute TVW
Original Assignee
Institute for Child Health Research
Telethon Kids Institute TVW
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute for Child Health Research, Telethon Kids Institute TVW filed Critical Institute for Child Health Research
Publication of EP0705108A1 publication Critical patent/EP0705108A1/de
Publication of EP0705108A4 publication Critical patent/EP0705108A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP94916845A 1993-06-02 1994-06-01 Verwendung von kryptischen peptiden zur induktion immunologisches toleranz Withdrawn EP0705108A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7283293A 1993-06-02 1993-06-02
US72832 1993-06-02
PCT/AU1994/000292 WO1994027634A1 (en) 1993-06-02 1994-06-01 Cryptic peptides for use in inducing immunologic tolerance

Publications (2)

Publication Number Publication Date
EP0705108A1 EP0705108A1 (de) 1996-04-10
EP0705108A4 true EP0705108A4 (de) 1997-08-06

Family

ID=22110024

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94916845A Withdrawn EP0705108A4 (de) 1993-06-02 1994-06-01 Verwendung von kryptischen peptiden zur induktion immunologisches toleranz

Country Status (6)

Country Link
EP (1) EP0705108A4 (de)
JP (1) JPH09509135A (de)
AU (1) AU674584B2 (de)
CA (1) CA2164326A1 (de)
NZ (1) NZ266739A (de)
WO (1) WO1994027634A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7726094A (en) * 1994-09-02 1996-03-27 Immulogic Pharmaceutical Corporation Peptide compositions capable of down regulating an antigen specific immune response
US6759234B1 (en) 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
KR19990063648A (ko) * 1995-09-21 1999-07-26 프레드한 아룬디프 에스 글루타민산 데카복실라제에 대한 항체와 폴리(에틸렌 글리콜)공액물을 섬세포에 제공하는 방법
JPH09194393A (ja) * 1996-01-22 1997-07-29 Meiji Milk Prod Co Ltd 免疫寛容を誘導する方法、免疫寛容誘導食品キットおよび免疫寛容誘導剤キット
CA2247009C (en) * 1996-03-21 2009-08-04 Imperial College Of Science, Technology And Medicine Cryptic peptides and method for their identification
US7097845B2 (en) 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
US6024961A (en) * 1997-11-14 2000-02-15 Washington University Recombinant avirulent immunogenic S typhi having rpos positive phenotype
US7128921B1 (en) 1998-04-17 2006-10-31 Heska Corporation Dermatophagoides proteins and fragments thereof
US6455686B1 (en) * 1998-04-17 2002-09-24 Heska Corporation Dermatophagoides nucleic acid molecules, proteins and uses thereof
FR2822709B1 (fr) * 2001-03-30 2007-01-19 Antialis Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
EP1718331A4 (de) * 2004-02-06 2009-11-11 Greer Lab Inc Verfahren und zusammensetzungen zur dosierung von allergenen
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
MX2010001779A (es) 2007-08-15 2010-07-06 Circassia Ltd Peptidos para vacunas.
KR20220166879A (ko) 2012-06-21 2022-12-19 노쓰웨스턴유니버시티 펩티드 접합된 입자
SI3033102T2 (sl) 2013-08-13 2024-03-29 Northwestern University Peptid konjugirani delci
JP7194593B2 (ja) 2015-12-23 2022-12-22 クール ファーマシューティカルズ ディベロップメント カンパニー インコーポレイテッド 共有ポリマー抗原コンジュゲート化粒子

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008279A1 (en) * 1991-10-16 1993-04-29 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624077B2 (en) * 1987-06-17 1992-06-04 Institute For Child Health Research Cloning of mite allergens
CA1336954C (en) * 1987-06-24 1995-09-12 Howard L. Weiner Treatment of autoimmune diseases by oral administration of autoantigens
DK0506785T3 (da) * 1989-12-20 2000-07-24 Autoimmune Inc Forbedret behandling af autoimmune sygdomme ved aerosol-administration af autoantigener
HUT61896A (en) * 1990-03-02 1993-03-29 Autoimmune Inc Process for producing orally administrable pharmaceutical compositions comprising autoantigenes, suitable for improving down-control of autoimmune diseases
AU650065B2 (en) * 1990-09-06 1994-06-09 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur Inhibitor of lymphocyte response and immune-related disease
DK0547164T3 (da) * 1990-09-07 2004-10-25 Univ California Fremgangsmåder til diagnosticering og behandling af diabetes
IL99754A (en) * 1990-10-15 1996-08-04 Autoimmune Inc Pharmaceutical preparation containing autoantib or particle or analogue for the treatment of autoimmune arthritis and multiple sclerosis
ATE228373T1 (de) * 1992-02-28 2002-12-15 Autoimmune Inc Unterdrückung von autoimmunkrankheiten durch antigene in wartestellung
IL105153A (en) * 1992-03-25 1999-12-22 Immulogic Pharma Corp Therapeutic compositions comprising peptides derived from human t cell reactive feline protein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008279A1 (en) * 1991-10-16 1993-04-29 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
H.YSSEL ET AL.: "T cell activation-inducing epitopes of the house dust mite allergen Der pI", JOURNAL OF IMMUNOLOGY, vol. 148, no. 3, 1 February 1992 (1992-02-01), BALTIMORE US, pages 738 - 745, XP002025554 *
P.JEANNIN ET AL.: "Specific histamine release capacity of peptides selected from the modelized De P I protein, a major allergen of Dermatophagoides pteronyssinus", MOLECULAR IMMUNOLOGY, vol. 29, no. 6, June 1992 (1992-06-01), pages 739 - 749, XP002025555 *
See also references of WO9427634A1 *

Also Published As

Publication number Publication date
AU674584B2 (en) 1997-01-02
JPH09509135A (ja) 1997-09-16
NZ266739A (en) 1997-07-27
WO1994027634A1 (en) 1994-12-08
EP0705108A1 (de) 1996-04-10
CA2164326A1 (en) 1994-12-08
AU6838594A (en) 1994-12-20

Similar Documents

Publication Publication Date Title
GB9319588D0 (en) Device for use in oculokinetic perimetry
EP0705108A4 (de) Verwendung von kryptischen peptiden zur induktion immunologisches toleranz
GB2277450B (en) Device for use in lithotrity
GB2272276B (en) Improvements in LPG cylinders
GB9106157D0 (en) Improvements in containers
IL105153A0 (en) Peptides useful for tolerization
EP0578127A3 (en) Mechanical in situ curometer
GB9224477D0 (en) Improvements in bodyforms
GB2284596B (en) Improvements in containers
GB9409941D0 (en) Improvements in connecting means
GB9206826D0 (en) Improvements in lighting apparatus
LTIP1981A (en) Pack for use in for horminal replacement therapy
ZA944483B (en) Peptides for use in medicine
GB9219126D0 (en) Improvements in orreries
GB8817657D0 (en) Improvements in containers
GB9322693D0 (en) Improvements in cryogenic apparatus
GB2268712B (en) Improvements in life-jackets
GB9222237D0 (en) Improvements in cryogenic apparatus
GB2281252B (en) Improvements in document storage systems
GB9301645D0 (en) Improvements in cranking systems
GB9303723D0 (en) Peptides for use in alleviating degenerative conditions
GB9423830D0 (en) Improvements in cryogenic apparatus
GB9120811D0 (en) Improvements in cryogenic apparatus
GB9307118D0 (en) Improvements in containers
GB9304002D0 (en) Warming means

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951211

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: TVW TELETHON INSTITUTE FOR CHILD HEALTH RESEARCH

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000101